Latest News
Pharmalys at the EDCTP Forum, Kigali 2025
Pharmalys participated as an exhibitor at the EDCTP Forum 2025, held from 15 to 20 June 2025 in Kigali, Rwanda. The event brought together a diverse community of stakeholders, providing a unique platform for collaboration, learning, and visibility. This year’s theme,...
July 2025 Newsletter: Female Genital Mutilation, Project Management Training, Pharmalys Regulatory Affairs and Study Start-Up Services
Female Genital Mutilation/Cutting: Understanding the Ongoing Global Crisis Female genital mutilation (FGM) is defined by the World Health Organization (WHO) as ‘all procedures which intentionally alter or damage the external female genitalia organs for non-medical...
Highlights from the Pharmalys Voice meeting, June 2025
On June 26, 2025, Pharmalys held its second Pharmalys Voice meeting of the year, bringing together colleagues from across the company in a dynamic and interactive virtual gathering. The meeting was marked by thoughtful presentations, engaging discussions, and a sense...
Female Genital Mutilation/Cutting: Understanding the Ongoing Global Crisis
Female genital mutilation (FGM) is defined by the World Health Organization (WHO) as ‘all procedures which intentionally alter or damage the external female genitalia organs for non-medical reasons and which have no benefit for the health of young girls and women.’...
Pharmalys Supports #Red4Research: Celebrating the People Behind Groundbreaking Health Advances
At Pharmalys, we proudly stand alongside the global community championing health and social care research through the #Red4Research initiative. This movement honours the countless individuals, research participants, patients, healthcare professionals, volunteers, and...
Advancing African Clinical Research Capacity: Pharmalys at TCIS Africa 2025
Pharmalys was pleased to participate in TCIS Africa 2025, an important gathering of clinical research professionals from across the continent. The event underscored the progress being made in Africa’s research landscape, while also highlighting the essential work...
May 2025 Newsletter: Senegal Achieves WHO Maturity Level 3, Improving Patient Understanding in Informed Consent, LEAP Africa and Mastercard Foundation Visit Pharmalys
Senegal Leads the Way: First Francophone African Country to Achieve WHO Maturity Level 3! We are thrilled to celebrate a significant achievement in global health and pharmaceutical innovation: Senegal has become the first Francophone country – and seventh country - in...
Pharmalys Capacity Building Programme in Nigeria and Sierra Leone, September 2024 to February 2025
Since September 2024, Pharmalys have conducted a series of capacity-building training sessions across four clinical research sites in Nigeria and Sierra Leone. Led by Mr. Assane Ndiaye and Mrs. Aissatou Ndour, the programme focused on equipping site staff with...
Did You Know That Africa Can Host Your Clinical Study? Pharmalys at the Clinical Outsourcing Summit 2025
At this year’s Clinical Outsourcing Summit (COS) in April 2025, Dr. Karim Bagaté, Director of Clinical Operations and Safety at Pharmalys, delivered a presentation on a topic very close to our hearts, titled “Did you know that Africa can host your clinical study?”....
Clinical Trials Day: Pharmalys on Building Inclusive Clinical Trials in Africa and Beyond
Each year on 20 May, Clinical Trials Day marks the anniversary of James Lind’s pioneering scurvy trial in 1747. More than 275 years later, clinical trials remain one of the most powerful tools we have for improving health outcomes, generating evidence, and shaping the...